Veerhealth Care is currently trading at Rs. 24.10, up by 2.04 points or 9.25% from its previous closing of Rs. 22.06 on the BSE.
The scrip opened at Rs. 24.21 and has touched a high and low of Rs. 24.39 and Rs. 23.23 respectively. So far 1270553 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.10 on 23-Feb-2024 and a 52 week low of Rs. 13.60 on 13-Dec-2023.
Last one week high and low of the scrip stood at Rs. 24.39 and Rs. 20.00 respectively. The current market cap of the company is Rs. 47.94 crore.
The promoters holding in the company stood at 30.41%, while Non-Institutions held 69.59% in the company.
Veerhealth Care has received an additional export order worth $106,673 (approximately Rs 89 lakh), also company is expecting monthly repeat orders from the same Top US Institutional Supplier. In addition to this, company is renovating its existing plant in Vapi, Gujarat to set up a bigger plant which will be US FDA & WHO compliant.
This new order underscores the continued trust and satisfaction of company valued international partners and marks a significant milestone in company's growth trajectory. The order will be executed within three months, as stipulated by the terms of the purchase agreement.
The company has executed & delivered Export Order valued at $50,000 (approximately Rs 41.50 lakh), another export order valued at $197,793 (approximately Rs 165 lakh) which shall be fully executed and delivered by end of July.
Veerhealth Care is engaged mainly in business of trading and manufacturing and marketing research based ayurvedic medicines.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |